Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dialysis01:27

Dialysis

1.8K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.8K
Dialysis01:15

Dialysis

2.1K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

2.9K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
2.9K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

1.6K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
1.6K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

787
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
787
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

329
Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
329

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Growing Problem of Hepatitis C Virus Infection: The Case of West Virginia.

The health care manager·2019
Same author

Still an Epidemic: The Burnout Syndrome in Hospital Registered Nurses.

The health care manager·2019
Same author

Medical Scribes: The Future for Medical Data Input in Emergency Departments.

Hospital topics·2018
Same author

International Classification of Diseases, Tenth Revision Implementation: Is the Workforce Ready?

The health care manager·2017
Same author

Maryland's All-Payer Health Care System: A Light at the End of a Tunnel.

The health care manager·2017
Same author

Insurance Companies Adapting to Trends by Adopting Medical Tourism.

The health care manager·2017

Related Experiment Video

Updated: Mar 19, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K

Renal Dialysis and its Financing.

Marisa Borelli1, David P Paul2, Michaeline Skiba2

  • 1a Marjorie K. Unterberg School of Nursing and Health Studies , Monmouth University , West Long Branch, New Jersey , USA.

Hospital Topics
|June 18, 2016
PubMed
Summary

Government reforms to dialysis payment systems aim to reduce end-stage renal disease (ESRD) expenditures. This study examines the impact of these changes on dialysis facilities, physicians, and patients facing rising ESRD rates.

Keywords:
End-stage renal disease (ESRD)Medicaredialysispayment reform

More Related Videos

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Related Experiment Videos

Last Updated: Mar 19, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

16.2K
A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

3.3K
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
05:34

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

1.9K

Area of Science:

  • Nephrology
  • Health Economics
  • Public Health Policy

Background:

  • Rising incidence of end-stage renal disease (ESRD) and its comorbidities (diabetes, hypertension) in aging populations.
  • Medicare coverage for most ESRD patients necessitates government intervention in reimbursement.
  • Increasing healthcare expenditures associated with ESRD treatment.

Purpose of the Study:

  • To analyze the effects of U.S. government reforms on dialysis facility payment systems.
  • To evaluate the impact of reduced reimbursement rates, bundled payments, and quality incentives.
  • To understand the consequences for kidney dialysis units, healthcare providers, and patients.

Main Methods:

  • Review of U.S. government payment system reforms for dialysis facilities.
  • Analysis of reduced reimbursement rates and bundled payment models.
  • Examination of quality incentive programs within the ESRD payment system.

Main Results:

  • The study examines the effects of specific payment reforms on the dialysis system.
  • It investigates the influence of reimbursement changes and quality incentives.
  • The impact on dialysis units, physicians, and patients is under review.

Conclusions:

  • Government reforms are reshaping the financial landscape of dialysis care.
  • Understanding these changes is crucial for stakeholders in the ESRD treatment pathway.
  • The long-term effects on quality of care and patient outcomes require ongoing assessment.